Medtronic plc (NYSE:MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart ...

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in ...

CHICAGO (Reuters) - Medtronic Inc is counting on an array of new medical devices to revive revenue growth, but the fate of its shares may hinge on defending its turf in its core heart rhythm business, ...

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success DUBLIN and BARCELONA, ...

DUBLIN and NEW ORLEANS, May 20, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced longer-term follow-up results of its investigational EV ICD™ System, ...

EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature DUBLIN, Feb. 17, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the ...

CHICAGO, Feb 19 (Reuters) - Medical device maker Medtronic Inc on Tuesday reported sharply lower net earnings on charges related to the acquisition of spinal products company Kyphon Inc. Sign up here.

Medtronic has reported positive results for its global Extravascular implantable cardioverter defibrillator (EV ICD) pivotal trial for patients at risk of sudden cardiac death. The data from the study ...

Medtronic has secured an FDA green light for a new type of implantable cardioverter-defibrillator that the medtech giant describes as the first of its kind. Unlike other ICDs that are wired into ...

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins FDA approval of the Medtronic Aurora EV-ICD system includes the system's ...